通过增强的分子模拟揭示了改进的CGRP结动学的决定因素
Ceren Kilinc1, Katie M Babin2, Augen A Pioszak2
1Michigan State University, Department of Biochemistry and Molecular Biology, East Lansing, Michigan 48824, USA.
bioRxiv : the preprint server for biology
|July 16, 2025
概括
与原生CGRP相比,工程化 ssCGRP 在CLR:RAMP1复合体上停留时间长430倍. 这种增强的结合稳定性,由特定的分子相互作用驱动,为开发长效疗法提供了见解,用于像偏头痛这样的疾病.
科学领域:
- 生物化学 生物化学
- 计算生物学 计算生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 类是有价值的治疗因其效能和安全性.
- 蛋白质结合动力学影响药物的疗效和稳定性.
- CLR:RAMP1复合体和CGRP是偏头痛病理生理学的关键.
研究的目的:
- 对原生CGRP和工程 ssCGRP 的结合机制进行比较分析.
- 为了阐明ssCGRP增强的居住时间的分子基础.
- 为设计下一代疗法提供见解.
主要方法:
- 利用高维权集算法进行计算分析.
- 对比原生CGRP和工程 ssCGRP 的解绑路径组合.
- 采用马尔科夫状态建模来分析绑定过渡状态和提交值.
主要成果:
- 与CGRP相比,ssCGRP在CLR:RAMP1上的停留时间长了430倍.
- 确定了稳定ssCGRP结合的特定的分子内和分子间相互作用.
- ssCGRP表现出增强的连接体重新捕获和更稳定的结合状态组合.
结论:
- 在CLR:RAMP1中阐明了停留时间的分子决定因素.
- 工程可以实现显著增强的结合动力学.
- 这些发现指导了长效治疗药物的设计,具有优化的特性.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.4K
05:57Author Spotlight: In Silico Creation and Impact of Carbonylated Amino Acids on Protein Structure and Function
Published on: April 26, 2024
490
相关概念视频
01:09GPCRs Regulate Adenylyl Cylase Activity
5.9K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
5.9K
01:16Protein-Drug Binding: Mechanism and Kinetics
975
Protein-drug binding refers to the interaction between drugs and proteins within the body. This binding process can occur intracellularly, involving drug interactions with enzymes or receptors within cells, or extracellularly, involving plasma proteins in the blood.
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
Various forces drive these interactions, including hydrogen bonds, hydrophobic interactions, ionic bonds, electrostatic interactions, and van der Waals forces. These bonds enable drugs to bind to specific sites on proteins,...
975